Your browser doesn't support javascript.
loading
Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs).
Orr, Katy; Buckley, Niamh E; Haddock, Paula; James, Colin; Parent, Jean-Luc; McQuaid, Stephen; Mullan, Paul B.
Afiliación
  • Orr K; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Buckley NE; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Haddock P; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • James C; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Parent JL; Université de Sherbrooke, Sherbrooke, Canada.
  • McQuaid S; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Mullan PB; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
Oncotarget ; 7(34): 55458-55472, 2016 Aug 23.
Article en En | MEDLINE | ID: mdl-27487152
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptores de Tromboxano A2 y Prostaglandina H2 / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptores de Tromboxano A2 y Prostaglandina H2 / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article